Financial comparisons VYNE Therapeutics Inc.
Equities
VYNE
US92941V3087
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.325 USD | -3.53% |
|
-1.29% | -31.64% |
Revenues (N-1) | Net margin (N-1) | EBIT margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
---|---|---|---|---|---|---|---|
424K | 6,710.38% | 6,900.47% | - | - | - | ||
9.87B | 36.68% | 44.33% | 22.99% | 17.71% | -2.46x | ||
14.2B | 31.07% | 36.33% | 19.23% | 15.02% | -1.12x | ||
1.29B | 23.26% | 33.51% | 8.54% | 7.69% | 10.14x | ||
4.22B | 24.36% | 18.08% | 4.62% | 4.02% | -13.1x | ||
2.46B | 35.86% | 49.12% | 22.26% | 14.47% | 2.05x | ||
5.69B | 26.5% | 29.43% | 18.99% | 15.45% | -0.64x | ||
305M | 245.59% | 232.51% | - | 50.2% | -0.8x | ||
1.89B | 13.23% | 13.3% | 12.68% | 8.89% | -5.76x | ||
2.44B | 26.42% | 32.3% | 14.78% | 13.31% | -5.01x | ||
2.4B | 19.96% | 24.97% | 9.02% | 6.41% | -0.78x | ||
1.24B | 43.11% | 21.54% | 86.15% | 1.86% | 1.96x | ||
1.83B | 11.35% | 9.34% | 8.74% | 6.91% | -5.06x | ||
638M | 44.81% | 45.26% | 55.36% | 27.64% | 0.65x | ||
295M | 180.51% | 170.79% | 818.43% | 50.27% | -0.33x | ||
50.83M | 205.3% | 166.94% | 58.43% | - | 2.98x | ||
Average | 3.05B | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | -1.15x | |
Weighted average by Cap. | 6.82B | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | -1.17x |
- Stock Market
- Equities
- VYNE Stock
- Sector VYNE Therapeutics Inc.
- Financial comparisons